Zoetis (ZTS)
(Delayed Data from NYSE)
$169.44 USD
-1.36 (-0.80%)
Updated May 30, 2024 04:00 PM ET
After-Market: $171.49 +2.05 (1.21%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Zoetis Inc. [ZTS]
Reports for Purchase
Showing records 181 - 200 ( 254 total )
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
Company: Zoetis Inc.
Industry: Medical - Drugs
On January 12, 2016, Zoetis provided an update on the company?s tax outlook for 2016 and 2017 following the European Commission?s decision to reverse certain Belgium tax benefits.
Provider: G.RESEARCH, LLC
Analyst: KEDRA K